Healthtech & Wellness VC Funds

Sukna Ventures is an early-stage venture capital firm based in Riyadh, with a strong focus on digital transformation across the MENA region. The firm backs startups from pre-seed to Series B, particularly in sectors like fintech, gaming, education, health tech, and enterprise software. Their geographic focus spans key markets, including Saudi Arabia, UAE, Jordan, Egypt, and Bahrain, aligning with regional growth trends in technology and innovation. Sukna Ventures is dedicated to investing in entrepreneurs who are building the next wave of high-growth ventures, leveraging cutting-edge technologies such as AI, machine learning, blockchain, and AR/VR. The firm supports companies that adapt to evolving market dynamics and regulations, empowering founders to scale their businesses in a rapidly transforming digital economy. With offices in Riyadh, Jeddah, and Abu Dhabi, Sukna Ventures is well-positioned to tap into local and regional opportunities, while maintaining a global perspective. The team, comprised of seasoned investors and entrepreneurs, plays a hands-on role in nurturing portfolio companies, offering strategic advice and access to a broad network. Notable investments include startups like Quantums, an ad-tech solution enhancing e-commerce media, and Earn Alliance, a platform empowering gamers in the web3 space. Sukna Ventures prides itself on creating meaningful impact, helping ventures reshape how we live, work, and play in the digital age.

Sultan Ventures is a boutique early-stage venture capital firm founded in 2009 and based in Honolulu, Hawaii. It was co-founded by managing partners Omar Sultan and Tarik Sultan, with Dr. Aya Sultan as a founding partner; Meli James serves as Head of New Ventures, directed the XLR8UH accelerator, and is President of the Hawaii Venture Capital Association. The firm is largely sector-agnostic but concentrates on pre-seed and seed financing rounds alongside preferred investment partners, typically as a co-investor. Its sector interests span healthcare, biotech, edtech, fintech, entertainment, information technology, aviation, energy, food and beverage, and consumer products. Sultan Ventures looks for visionary founders building sustainable businesses, placing heavy emphasis on education and strong team dynamics, and provides due diligence, deal sourcing, capital-raise and business-planning support through its network of experts and investors. It operates XLR8UH, an award-winning venture accelerator investing in University of Hawaii entrepreneurs and technologies that Forbes named among the top 30 US accelerators, and manages the Upside Fund, which can invest up to $600K in companies using University of Hawaii intellectual property. As of 2016 it had invested in around 23 companies, with notable holdings including RedVox Infrasound, MeetingSift and SimpliFed. The firm has expanded internationally through the acquisition of Acasia Group, targeting opportunities in the Middle East and Africa. By anchoring itself in Hawaii's university and startup ecosystem, Sultan Ventures backs founders and commercializes academic innovation.

Summit Partners is a global investment firm that focuses on growth equity, managing more than $37 billion in capital. Founded in 1984, it has invested in over 550 companies across key sectors such as technology, healthcare, and growth products & services. Summit is known for backing companies with strong growth potential, offering both minority and majority investments, with a typical check size ranging from $10 million to over $500 million. The firm partners with companies that demonstrate leadership in their respective industries, providing not just capital but also strategic resources through its Peak Performance Group. This dedicated team supports portfolio companies in areas like operations, M&A, and capital markets, ensuring they scale efficiently. Summit has a strong global presence, with offices in Boston, Menlo Park, New York, London, and Luxembourg, and focuses heavily on profitable growth as a key driver of long-term value creation. Notable portfolio companies include technology giants like Klaviyo and cybersecurity firm Darktrace. Summit's hands-on, collaborative approach has made it a top choice for companies looking to scale rapidly while maintaining profitability​.

Sunicon Ventures is an early-stage venture capital firm founded in 2018 and based in Mumbai, India, structured as an Alternate Investment Fund (AIF). It is the institutional venture arm of the family behind Sun Capital Advisory Services, a boutique investment bank established by Suresh Jain in 2006, and it grew out of an earlier family investment fund. The firm is led by Managing Partner Suresh Jain alongside Founding Partners Saloni Jain, a Harvard Business School alumna and investment-banking partner at Sun Capital, and Darshan Jain, drawing on more than three decades of combined investment experience. Sunicon describes itself as sector-agnostic, investing in disruptive Indian startups across artificial intelligence and machine learning, fintech, consumer and direct-to-consumer brands, healthcare, edtech, agritech, biotech, blockchain, AR/VR and Web3. It writes seed to pre-Series A cheques typically ranging from US $100,000 to $500,000, around $300,000 on average, and provides strategic guidance, mentorship and network access, generally as a co-investor. Reported fund-size figures range from roughly INR 830 million, about $10M, to $20M. As of January 2026 it was an active investor in around 23 companies, with four new investments in the prior twelve months. Notable portfolio companies include footwear D2C brand Neeman's, performance-nutrition company Neulife, edge-AI semiconductor startup Sensesemi, culture-led gaming brand Chittam, mixed-reality glasses maker Anjalens, and edtech firms Saarthi Pedagogy and Vidyakul. Backed by an investment-banking heritage, Sunicon Ventures supports early-stage Indian founders across a broad technology landscape.

Sunsino Venture Group is one of Taiwan's leading multi-asset alternative investment firms, founded in 1993 and headquartered in Taipei. Over a track record spanning more than three decades it has cumulatively managed 16 venture investment funds, including vehicles backed by Taiwan's government and National Development Council, and currently oversees roughly NT$4 billion, about US$150 million, in assets. The firm is led by Chairman and Managing Partner Vincent Wang, a Wharton MBA, chairman of the Taiwan Angel Investors Association and board member of the Taiwan Venture Capital Association, alongside Partner and STARTUP101 CEO Cami Lu. Sunsino invests in innovative and disruptive startups in healthcare, technology and software, with particular emphasis on AI, IoT, medtech and ESG companies that have working demos or MVPs validated by reputable industry players or initial sales. It also backs enterprise applications, food and agriculture tech and life sciences, supporting global entrepreneurs across its core markets of Taiwan, Japan, Korea, Southeast Asia and the United States. The firm writes cheques typically in the US$5 to 10 million range, investing from Series A through later growth rounds as a lead investor while advising founders on operating strategy, follow-on fundraising and exit planning. It has invested in over 200 companies with roughly 80 IPO and M&A outcomes; notable names include Cardival Medical, Loopd and Advanced Analogic Technologies. With three decades of fund management and a pan-Asian and US footprint, Sunsino Venture Group is an established growth-stage technology and healthcare investor.

Supermoon Capital is a pioneering venture capital firm exclusively focused on the rapidly growing sleep industry, which they refer to as the "Night Market™." Launched in 2021 with a $36 million fund, Supermoon Capital seeks to address the global epidemic of insufficient sleep, which affects 75% of Americans and has been declared a public health crisis by the CDC. The firm invests in early-stage startups across various sectors, including software, medical devices, and consumer products, all aimed at improving sleep health through science-backed innovations. The firm’s portfolio is diverse, featuring companies like Endel, an AI-driven platform that creates personalized soundscapes to enhance sleep and reduce stress, and EnsoData, which uses FDA-cleared AI software to assist clinicians in diagnosing sleep disorders like sleep apnea. Other notable investments include FreshBed, a Netherlands-based company that designs beds optimizing air quality, temperature, and humidity for better sleep, and Clair Labs, an Israeli startup revolutionizing patient monitoring with contact-free technology for clinical-grade physiological monitoring. Supermoon Capital was co-founded by industry veterans Pat Connolly, Michael Masterson, and Grayson Judge. Connolly, with his extensive background at Williams-Sonoma, brings a wealth of experience in business strategy and e-commerce. Masterson and Judge contribute deep expertise from the healthcare and venture capital sectors. Together, they provide more than just capital; they offer a robust network of sleep science experts and strategic partners to help their portfolio companies succeed. Supermoon Capital is positioned as the premier source of expertise and funding in the emerging sleep economy.

Supernode Ventures, founded in 2017 by Laurel Touby, is an early-stage venture capital firm based in New York. The firm is sector-agnostic, with a portfolio spanning across fintech, healthtech, B2B, and B2C companies. Supernode primarily invests in pre-seed and seed-stage startups, often providing the first institutional checks for emerging companies. Their typical check sizes range from $500,000 to $1 million. Supernode’s portfolio includes notable companies like Braze (IPO in 2021), BBOT (acquired for $100 million), Electric.ai, and DeepScribe.ai. The firm is known for backing innovative startups in healthcare, e-commerce, and supply chain technologies, among other industries. The firm's investment strategy revolves around identifying founders with resilience and a strong sense of control over their destiny, a key trait Laurel Touby emphasizes. Supernode is also heavily network-driven, leveraging extensive industry connections to help its portfolio companies grow. With over 50 companies backed in its first fund, Supernode Ventures has positioned itself as a key player in the early-stage investment ecosystem, focusing on scalable tech solutions that have the potential to transform their respective industries.

Surface Ventures is a pre-seed and seed-stage venture capital firm based in New York, focusing on investments in B2B software companies. With a $50 million fund, they primarily target startups with pre-money valuations below $15 million, and their median first check size is approximately $900,000. Surface Ventures believes in investing in design-centric companies, emphasizing the importance of brand and user experience to create enduring businesses​. The firm’s portfolio includes notable companies such as Mirror, Aether, Canopy, and Juni, reflecting their commitment to sectors like SaaS, CRM, and analytics. Surface Ventures looks for companies that solve real problems and have strong, competitive management teams. For startups looking to engage with Surface Ventures, it's crucial to demonstrate a clear market need and a passionate, capable team. The firm prefers to lead rounds and offers substantial support beyond capital, leveraging their expertise to help startups navigate early-stage growth challenges.

Susa Ventures is a seed-stage venture capital firm based in San Francisco, named after the Susa family of mountain gorillas in Rwanda. The firm focuses on investments in sectors such as fintech, healthcare, logistics, enterprise software, and infrastructure and development tools. Susa Ventures seeks out businesses with strong compounding moats, like proprietary data, economies of scale, and network effects. Founded by Seth Berman and Chad Byers, Susa Ventures has backed notable companies like Robinhood, Flexport, and Viz.ai. The firm typically invests between $1 million and $3 million in seed rounds and is known for being a supportive and accessible partner to its portfolio companies. Susa Ventures prides itself on creating a deeply connected community of founders, investors, operators, advisors, and service providers. The team at Susa Ventures includes experienced professionals from various backgrounds, all committed to helping entrepreneurs succeed. Their investment process involves a few introductory meetings followed by a full partner meeting and thorough reference checks.

Sussex Place Ventures is an early-stage venture capital firm based in London, founded in 1998 in support of London Business School's entrepreneurship programmes, with which it remains an independently managed associated venture capital company. It backs entrepreneurs building B2B enterprise software and strong, patent-protectable deep technology, investing at an early stage in software and SaaS businesses, IP-rich technology companies, and digital and internet businesses that show evidence of user traction; it also maintains a life-sciences and medtech thread. The firm typically makes an initial investment of up to £1 million per company and then follows on over the company's life, and is willing to lead rounds. Its most recent vehicle, Regents Park Partners II, was a £30m, roughly $51m, fund, two-thirds of which was committed by the UK government's British Business Bank through its Enterprise Capital Fund programme, with the balance from private investors, exited technology entrepreneurs, angels and London Business School alumni. The team is led by Joint Managing Partner Barnaby Terry, alongside Operating Partner John Mark Brimacombe and Investment Director Ivan Shyr. Sussex Place Ventures has built a portfolio of around 20 companies across the UK and US, including Chaser, a SaaS invoice-chasing company; Endomag, a magnetic-sensing breast-cancer medtech business; Kimble; Phase Focus; and Server Density. It has recorded multiple exits, most notably Skimlinks, the commerce-content monetization platform sold to Connexity in June 2020, plus Server Density and LaunchPad Recruits. With deep ties to London Business School, the firm backs IP-rich B2B software founders.

SustainVC is an impact-focused venture capital firm that manages a series of funds aimed at early-stage companies creating significant social and environmental impact. Founded in 2007, SustainVC backs innovative entrepreneurs whose ventures align with their vision of a sustainable, equitable, and healthier world. The firm typically invests between $500,000 to $5 million in companies within sectors like Climate & Sustainability, Equality & Empowerment, and Health & Education. With offices in Boston, Philadelphia, and Durham, SustainVC's team brings over 100 years of combined experience in investing, startups, and consulting. They prioritize investments that promise both measurable impact and competitive financial returns. Notable portfolio companies include Ocean Renewable Power Company, which focuses on emission-free, renewable energy from tides and rivers, and Goalbook, an educational software platform that supports individualized learning. SustainVC is committed to driving positive change while achieving market-rate returns, making them a key player in the impact investing landscape. Their hands-on approach ensures that they are deeply involved in scaling their portfolio companies, leveraging their extensive networks to help these businesses succeed.

Sutter Hill Ventures is one of the oldest venture capital firms still in operation, founded in 1964 by Bill Draper and Paul Wythes as an offshoot of a real estate firm and originally licensed as a Small Business Investment Company. Based in Palo Alto, California, the firm is famously low-profile and invests in technology-based startups across enterprise and infrastructure software, networking and computer technology, cloud, security, business and financial services, and healthcare. Its distinctive model is venture-studio-style company building: Sutter Hill originates only one or two companies a year, often incubating them in-house and embedding a partner as founding operator, then selectively backs a few other investments, exemplified by Managing Director Mike Speiser serving as Snowflake's founding CEO from 2012 to 2014 after leading its $5M Series A. The firm runs an evergreen structure in which the partners invest their own capital alongside LPs with no fixed fund life, and acts as a lead investor. It is led by Managing Directors including Mike Speiser, Stefan Dyckerhoff (founder of Nicira, acquired by VMware for $1.26B), Jim White, Keith Loebner and Divanny Lamas. Across decades Sutter Hill has backed more than 200 companies, with legendary outcomes including Snowflake, the largest software IPO ever, where the firm held over 20% worth roughly $12.6 billion; Pure Storage; Sumo Logic; Lacework; NVIDIA; and, more recently, Jony Ive's AI-hardware startup io, acquired by OpenAI for $6.5 billion in 2025. Its patient, builder-led approach has made it one of Silicon Valley's most enduring firms.

SV Angel, founded by Ron Conway in 2009, is a prominent venture capital firm based in San Francisco. Renowned for its focus on early-stage investments, particularly in technology and software sectors, SV Angel has been instrumental in the growth of numerous high-profile startups. Some of its notable investments include Stripe, Reddit, Notion, Headspace, Color, Patreon, Credit Karma, Poshmark, and GitHub. The firm is highly active in the startup ecosystem, making over 1,100 investments and achieving more than 450 exits. Significant exits include companies like Airbnb, Coinbase, DoorDash, and Slack. SV Angel is known for its founder-focused approach, providing not only capital but also strategic support without taking board seats, thus allowing founders greater operational freedom. SV Angel typically invests in seed rounds with average check sizes around $150,000. They do not lead funding rounds but prefer to collaborate with other investors. The firm has a history of supporting startups through special purpose vehicles for late-stage investments and growth equity funds, like the $269 million fund raised in 2022. The firm's leadership includes Ron Conway and his son Topher Conway, who continue to emphasize a community-oriented, hyper-engaged investment style. This strategy has positioned SV Angel as a vital player in fostering innovation within the tech industry.

SV Health Investors is a leading healthcare-focused venture capital firm with over 30 years of experience, specializing in biotechnology, medical devices, and healthcare services. Notable investments include companies like American Well, Nimbus Therapeutics, and Bicycle Therapeutics. Their portfolio spans groundbreaking areas such as precision medicine, dementia therapeutics, and digital health. The firm’s industry focus is deeply rooted in life sciences, with a particular emphasis on biotechnology, medtech, and healthcare growth opportunities. Their investments target startups across all stages, from early innovation to growth phases, with a sharp focus on transforming healthcare through innovative treatments. SV Health Investors operates globally, with key offices in Boston and London, primarily focusing on the US and UK markets. Their strategy revolves around creating value through a hands-on approach, often leading rounds and collaborating closely with entrepreneurs. They are known for their in-depth sector knowledge, especially in complex therapeutic areas, and provide capital along with operational expertise to help companies scale. The average check size varies by stage and sector, and SV is actively involved in both early-stage biotech ventures and more mature growth companies. The team is led by seasoned experts like Kate Bingham and Nikola Trbovic, combining extensive industry experience with a commitment to fostering diversity in their investments. Entrepreneurs seeking to approach SV should highlight strong scientific innovation and a clear path to clinical impact, as the fund prioritizes cutting-edge breakthroughs with high potential.

SV Latam Capital is a San Francisco-based venture capital firm that focuses on early-stage investments across Latin America. Founded in 2013 by Consuelo Valverde, the firm is dedicated to empowering innovative startups that address critical global challenges, particularly in the realms of health, sustainability, and technology. The firm’s mission is to support bold founders who are building businesses that have a positive impact on people and the planet. SV Latam Capital’s investment strategy emphasizes identifying and backing tech and science-driven companies with the potential to create transformative solutions. The firm’s portfolio includes companies that are pioneering advancements in sectors such as healthcare, clean energy, and fintech, reflecting its commitment to making a meaningful impact through its investments. The firm operates with a unique approach, leveraging its Silicon Valley roots to provide capital, mentorship, and strategic support to Latin American entrepreneurs. This approach has attracted a diverse group of investors, including notable names like Chris Sacca and PayPal, who recognize the significant potential in the Latin American market. SV Latam Capital has raised multiple funds, including its $22 million Fund II, which closed in 2021. This fund is designed to support the next generation of Latin American entrepreneurs, with a focus on scaling innovative solutions that can address global challenges. With its strong network and deep expertise, SV Latam Capital is well-positioned to continue driving positive change and fostering the growth of high-impact startups across the region​.

Silicon Valley Bank (SVB) has carved out a unique niche in the venture capital world by focusing on the innovation economy. Notable investments include high-profile startups like Airbnb and Uber, reflecting SVB’s emphasis on early-stage, high-growth companies. SVB’s industry focus spans technology, life sciences, healthcare, and premium wine sectors, providing tailored financial services to meet the specific needs of these industries. Geographically, SVB is active globally, with a significant presence in the United States, Europe, and Asia. This extensive reach allows them to support startups with ambitions to scale internationally. SVB’s investment strategy involves participating in early-stage funding rounds and providing venture debt, which helps companies extend their runways without diluting equity excessively. They typically lead funding rounds and often take board seats to offer strategic guidance. SVB has been active lately, with consistent investment activity even during market slowdowns. They prefer a hands-on approach, often advising companies on financial planning and operational efficiency. The average check size varies, but they are known for their substantial investments that can significantly propel a startup’s growth. Key team members include industry veterans like Greg Becker, who brings decades of experience in banking and venture capital, based in the firm's headquarters in Santa Clara, California. For startups looking to engage with SVB, a warm introduction through a shared connection or a strong business plan highlighting scalability and innovation can be effective ways to get noticed. SVB values relationships built on trust and strategic alignment, making it crucial for startups to demonstrate how they fit into SVB’s vision of the future.

THRIVE AgriFood, operated by SVG Ventures, is a premier global investment and innovation platform focusing on agtech and foodtech startups. Since its inception in 2010, THRIVE has built a robust portfolio of over 80 investments, including notable companies like Tortuga Agtech, Farmwise, and MilkMoovement. The firm is recognized as the most active AgTech investor globally, providing not just capital but also comprehensive support through its accelerator programs and strategic partnerships with leading corporations like Land O’Lakes, Bayer, and Shell. Based in Silicon Valley, THRIVE collaborates with a vast network of over 10,000 startups from 100 countries. Their investment strategy spans from Seed to Series A rounds, focusing on sustainable and innovative technologies that address critical challenges in the food and agriculture sectors. The firm also runs various programs and challenges to identify and support high-potential startups globally​. For startups, THRIVE offers extensive resources, including mentorship, market access, and corporate partnerships, designed to accelerate growth and drive impactful innovation. Their comprehensive approach ensures that startups are well-equipped to scale and succeed in the competitive agtech and foodtech landscapes.

Sweater Ventures, through its flagship Cashmere Fund, aims to democratize venture capital by offering access to private, high-growth companies for both accredited and non-accredited investors. Founded on the belief that VC should be available to everyone, Sweater leverages its app to pool capital from a wide base of retail investors and deploy it into consumer-focused startups. Their investments span industries like consumer goods, health tech, fintech, and SaaS, reflecting their focus on companies that directly impact everyday lives. Sweater operates with an evergreen fund model, meaning the Cashmere Fund continues to grow over time by regularly raising new capital and reinvesting into emerging opportunities. This large portfolio approach ensures diversification, mitigating some risks associated with venture investing. The fund primarily targets early-stage startups, but it also allocates capital to growth-stage secondaries and other venture capital funds as part of a broader strategy. The team at Sweater Ventures actively works to support its portfolio companies, helping them navigate the complex fundraising landscape and scale effectively. Despite tough economic conditions, Sweater's portfolio has shown positive growth, with standout companies like Accredible and others already raising follow-on rounds at higher valuations. Sweater's vision is to create a thriving community where both investors and founders can connect, fostering collaboration and growth. With a $500 minimum investment, Sweater opens doors to venture capital for everyone, reshaping the way people invest in innovation.

Swiftarc Ventures is an American early- and growth-stage venture capital firm founded in 2019 by Sid Jawahar, headquartered in New York City with an additional office in Miami, Florida. The firm focuses on the next generation of consumer and consumer-health disruptors, with an emphasis on consumer technology, enterprise telehealth, beauty and wellness, and food sustainability, typically investing as a co-investor. It operates through several distinct vehicles: a roughly $25M Swiftarc Ventures Labs Fund for early-stage consumer technology; the Swiftarc Telehealth Fund, launched in January 2022 with a $75M capacity and billed as the first telehealth-focused venture fund, targeting innovation in obesity, mental and behavioral health and pediatric care driven by US healthcare-delivery legislation; and a $10M Swiftarc Beauty Fund launched in August 2021 to back female-led beauty and wellness brands. Typical check sizes range from $100K to $10M with a sweet spot around $1M. The firm has made a small number of investments, roughly seven, with notable names including Intellihealth, R-Zero, Artiphon, FlyteHealth and Pause. For transparency, founder Sid Jawahar was the subject of a 2022 Texas State Securities Board cease-and-desist and adviser-registration revocation for overvaluing a fund position, and in December 2023 was indicted in the US District Court in St. Louis on three counts of wire fraud and one count of investment adviser fraud, with an arrest in Miami in January 2024. The firm's stated focus remains consumer and consumer-health innovation across its themed funds.

Switch Ventures, founded by Paul Arnold in 2014, is a venture capital firm based in San Francisco, California. The firm focuses on early-stage investments, aiming to back talented founders who diverge from conventional paths to create impactful startups. Switch Ventures has a strong commitment to diversity, with 70% of its portfolio companies founded by women or people of color. The firm has made 67 investments and achieved 10 notable exits, including companies like The Athletic, Mode Analytics, and Policygenius. Switch Ventures' diverse portfolio includes startups across various sectors such as fintech, health tech, and enterprise software. Notable investments include Pluto, Gridwise, and Turtle Health. Switch Ventures emphasizes building a strong community of founders and providing them with the support necessary to secure follow-on funding and achieve substantial growth. The firm is known for its founder-friendly approach and deep involvement in the startups it backs​.

SWS Venture Capital, founded by Steve Streit, the entrepreneur behind Green Dot, focuses on early-stage investments in consumer products and technology sectors. Established in 2018, SWS VC leverages Streit’s extensive experience in fintech and disruptive technologies, backing ambitious founders who are reshaping industries. The firm offers both active and passive investment models: in its active role, SWS partners with startups, providing not only capital but also strategic and operational guidance. As a passive investor, SWS co-invests alongside other leading venture capital firms, where it can add value through its domain expertise. SWS’s portfolio includes innovative companies like Greenlight, a financial platform for families, Gusto, a payroll and benefits platform, and Paloma Health, a telemedicine platform specializing in thyroid care. The firm’s investment strategy often centers on identifying and nurturing businesses that have the potential to scale significantly, with typical investment sizes ranging from early seed rounds to later stages through specialized SPVs. With headquarters in Los Angeles, SWS Venture Capital remains committed to driving disruption across multiple industries by supporting visionary founders with a focus on long-term growth and impactful exits.

Synchrony Ventures is the corporate venture capital arm of Synchrony Financial, the US consumer-finance and payments company, founded in 2017 and based in San Francisco, California. It makes direct, strategic early-stage investments in companies across financial services, commerce and healthcare, looking for technologies and teams that help Synchrony better serve its customers and accelerate its pace of innovation, typically as a strategic co-investor. The firm offers portfolio companies the power of Synchrony's ecosystem, more than 70 million consumers and over 300,000 partners, to help startups scale new products and services. Within financial services it backs platforms serving consumers, small businesses and large enterprises with tailored, scalable products; in commerce it invests in next-generation platforms that engage and delight customers; and in health and wellness it backs entrepreneurs improving the care journey, with a focus on healthcare financing and payments. Synchrony Ventures invests across seed, early-stage and later-stage rounds, with a geographic focus on the United States. It has made roughly 25 investments, including identity company Prove, embedded-checkout startup Skipify, blockchain-identity infrastructure firm Magic, and rewards and data platform Drop. The unit is led by Head of Synchrony Ventures Kelly Shaw, a former Vestigo Ventures partner and co-founder of AlmaPact and Clasp, alongside investor George Kitsios. By pairing capital with access to Synchrony's vast consumer and partner network, Synchrony Ventures backs founders building the future of financing, commerce and healthcare payments.

Synergy Ventures is a Menlo Park, California-based venture capital firm active in medical technology and venture capital since 1996, specializing in seed and early-stage investment in the medical device, medical technology, healthcare and biotechnology sectors. The firm seeks US medical device startups that can demonstrate clinical efficacy early and that have strong potential for strategic partnership and acquisition, typically writing initial checks of $250K to $1M alongside hands-on strategic guidance, usually as a co-investor. A distinctive feature is its affiliated consulting company, Synergy Partners International, which develops investment, distribution and strategic partnering relationships between US medical technology companies and Japanese corporate and financial clients, giving portfolio companies access to Japan and Pacific Rim partnerships and acquisition opportunities. Across its Synergy Ventures funds and Synergy Partners International, the firm reports participating in over $1 billion in equity and other financial transactions involving more than 70 private US medical technology companies. Its portfolio has produced multiple IPOs and acquisitions, including Align Technology, Omnicell and Companion Medical, with notable holdings such as Pulse Biosciences, Ocugen, Endra Life Sciences, Imprimis Pharma, Aqua Metals, ClearSign and Ideal Power. The firm is led by co-founders and managing directors Allan Johnston, Ph.D., formerly head of late-stage medtech private equity at Berkeley International Capital Corporation and a program manager at SRI International, and Robert Okun, M.I.M., a veteran of Japan and Pacific Rim syndication, fundraising and strategic equity arrangements. Synergy Ventures pairs medtech investing with a unique US-Japan partnering platform.

Syngenta Group Ventures is a venture capital arm based in Basel, Switzerland, focusing on innovative agri-food technologies and business models. They aim to transform agriculture by supporting startups that address global challenges such as climate change, food security, and sustainable farming. Notable investments include Sound Agriculture, which develops climate-smart agricultural solutions; Greeneye Technology, an AI-driven precision spraying system; and BioPhero, which creates sustainable biological alternatives to chemical pesticides. The fund primarily invests in early to late-stage companies across diverse geographies, with significant activity in North America, Europe, and Asia. Syngenta Group Ventures typically takes minority equity stakes and often co-invests with other venture and corporate funds. Their strategy revolves around identifying and nurturing groundbreaking innovations that improve farming economics and productivity. The average check size varies, but they actively lead rounds, particularly in Series B and beyond. Entrepreneurs are encouraged to approach them with scalable solutions that align with their mission of sustainable and profitable agriculture. The leadership team, including Managing Directors Michael Lee and Shubhang Shankar, brings extensive expertise in venture capital, technical sciences, and agribusiness. Syngenta Group Ventures stands out for its deep industry knowledge and commitment to leveraging technology for a better agricultural future.

Systema Nova is a London-based venture capital firm investing in early-stage AI and deep-tech startups, with a particular focus on climate, fintech and healthtech. Registered at 100 Cannon Street, London, the firm is authorised and regulated by the UK Financial Conduct Authority. It backs companies at the pre-seed and seed stages, writing typical cheques in the range of roughly EUR 100k to EUR 1.5M, generally as a co-investor. Systema Nova emphasises a hands-on model that provides growth acceleration through a network of go-to-market experts and strategic support to help founders enter and scale in new markets. Its investment areas span healthtech, deeptech, artificial intelligence and sustainability. Portfolio companies include Solence, a healthcare venture that has raised about $2.1M; HyveGeo, which develops microalgae-based solutions for carbon removal and sustainable agriculture; and Diesta, a payments and reconciliation platform for the insurance industry that has raised about $5.85M alongside co-investors such as Restive Ventures, SixThirty, Westerly and Antler. The firm is led by founder and CEO Stephane Mardel and General Partner Farid Haque. It is a distinct entity from Sistema Venture Capital, the Moscow-based corporate venture arm of Sistema. By combining FCA-regulated structure, early-stage focus and operational go-to-market support, Systema Nova backs founders building AI and deep-tech solutions for climate, financial-services and healthcare challenges across Europe.

T2 Venture Creation (T2VC) is a Silicon Valley seed and early-stage venture capital and advisory firm focused on high-impact innovation in the technology and healthcare sectors. Created in the mid-2000s and headquartered in Portola Valley, California, it was founded as the venture capital affiliate of the Larta Institute, which remained a partner. T2VC's distinctive model invests both money and time in startups spinning out of academia and government, drawing its deal pipeline from the National Institutes of Health, DARPA, the NIST Advanced Technology Program, more than 50 universities, and a network of over 40 innovation clusters across more than 20 countries. Typical deals fell in the $1M to $5M range, usually in rounds with two or three co-investors such as Tamiami Angel Funds, St. Louis Arch Angels and GSR Ventures. Areas of investment spanned biotechnology, water and water purification, nanotechnology, RFID, apps and education. Portfolio companies included GroundMetrics in electromagnetic sensing, Independa in aging-in-place healthcare technology, Liquidity Nanotech in nanotech water filtration and Stonybrook Purification. The firm is led by co-founders Victor W. Hwang, CEO and immediate past President of the Larta Institute, and Greg Horowitt, Managing Director, Executive Director of Global CONNECT and co-author of 'The Rainforest: The Secret to Building the Next Silicon Valley.' Its most active period was the early 2010s; tracked investment activity tapered after 2013 to 2014 as the principals moved into broader innovation-ecosystem roles. T2VC pioneered a hands-on model for commercializing academic and government research.

TA Ventures, founded in 2010 and headquartered in Kyiv, Ukraine, specializes in early-stage investments in tech startups. The firm focuses on sectors such as SaaS, AI, fintech, e-commerce, and digital health. TA Ventures has a significant portfolio of over 120 companies, including notable investments like Wrike, Rentberry, and Jiji. The firm typically invests in pre-seed and seed stages with average ticket sizes ranging from $100,000 to $500,000. They seek out ambitious startups with scalable business models and global potential. TA Ventures has a strong track record of successful exits, with over 42 companies having been acquired or gone public. Key team members include Viktoriya Tigipko, the Founder and Managing Partner, who has a rich background in entrepreneurship and technology, and Oleg Malenkov, a Partner based in Los Angeles who focuses on consumer tech. The team is spread across various locations, including the US, the Netherlands, and Southeast Asia, enabling them to leverage a broad network and diverse market insights. TA Ventures also co-invests with other prominent venture funds and angels, further supporting the growth and scalability of their portfolio companies.

Tabula Rasa Ventures is an investment firm specializing in healthcare and biotechnology, with a strong focus on psychedelic therapeutics. Founded in 2018, the firm seeks to fill critical gaps in the healthcare industry by investing in innovative startups across the biotech, drug development, and digital health sectors. Headquartered in New York, Tabula Rasa Ventures has become a leader in the psychedelic ecosystem, providing early-stage capital, incubation, and acceleration for groundbreaking ventures. The firm's investment strategy revolves around supporting startups from their inception through growth stages. They work hands-on with founders, offering deep expertise in scaling, regulatory affairs, and clinical trials. Tabula Rasa has built a diverse portfolio of companies like ATAI Life Sciences, Wavepaths, and Lykos Therapeutics, all of which are pushing the boundaries of mental health treatment and healthcare infrastructure. Led by Managing Partners Marik Hazan and Maria Velkova, Tabula Rasa Ventures takes a community-driven approach. They emphasize sustainable long-term growth by fostering trust among stakeholders, whether they are investors, patients, or regulators. With investments ranging from $50,000 to $1 million, the firm remains committed to transforming healthcare through cutting-edge solutions that address significant unmet needs in mental health and beyond. Their involvement in conferences such as the World Economic Forum.

Tacoma Venture Fund (TVF) is an early-stage venture capital firm based in Tacoma, Washington, that focuses on supporting startups across the Pacific Northwest. Founded in 2019 by Bill Driscoll, TVF is dedicated to empowering process-oriented founders who are building venture-scale technology companies. The firm primarily targets seed and Series A investments, working closely with entrepreneurs to help them navigate the path from early-stage development to scalable growth. TVF is sector-agnostic, making investments in industries ranging from enterprise software and healthcare to commercial products and electronic equipment. The firm takes a hands-on approach, offering founders not only capital but also strategic guidance and operational support. This approach includes helping founders refine their business strategies and providing an accountability layer to ensure long-term success. Notable investments in TVF's portfolio include Vega Cloud, Workflow Labs, and FlavorCloud, reflecting the firm's focus on disruptive technologies. With a mission to foster a strong venture ecosystem in the Pacific Northwest, TVF continues to support underrepresented founders and drive innovation in the region. The leadership team, including President Bill Driscoll and Director of Investments Dennis Joyce, brings deep experience in venture capital, entrepreneurship, and operational management. Together, they are committed to helping founders build successful, enduring companies.

Takeda Ventures, Inc. (TVI), founded in 2001, is the corporate venture capital arm of Takeda Pharmaceutical Company Limited. TVI focuses on early-stage, preclinical opportunities that align with Takeda's R&D pillars: Oncology, Rare Genetics & Hematology, Neuroscience, and Gastrointestinal & Inflammation. Their portfolio includes notable companies such as Amwell, Avidity Biosciences, and Xilio Therapeutics. TVI's investment strategy emphasizes high-caliber, therapeutic, platform-based companies worldwide, primarily in North America, Europe, and Japan. The average investment ranges from seed to Series B rounds, with TVI often co-investing alongside major venture firms like OrbiMed and Johnson & Johnson Innovation. TVI's approach includes taking board seats and providing strategic guidance, leveraging Takeda's extensive global resources and expertise to drive value-based outcomes for patients. The team is based in Cambridge, MA, and includes seasoned professionals like Miles Gerson (Head & President) and Jasmina Marjanovic, Ph.D. (Partner). They prioritize a hands-on, collaborative approach, working closely with portfolio companies to foster innovation and therapeutic advancements. TVI actively seeks to build relationships with academic innovators, entrepreneurs, and venture investors to cultivate a robust pipeline of breakthrough therapies. For startups looking to connect, TVI values companies with early commercial traction and those that embody a patient-first approach, reflecting Takeda’s core values.

Takeda Ventures, Inc. (TVI) is the corporate venture capital group of Takeda Pharmaceutical Company Limited, Japan's largest pharmaceutical company, founded in 2001 with the vision of generating disruptive technologies and therapeutic solutions for patients through venture-based investments. Operating under Takeda's Center for External Innovation, the firm specifically backs early-stage, preclinical opportunities and platform-based therapeutic companies around the world whose products complement Takeda's pipeline. Its investments are aligned with Takeda's core R&D pillars: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastrointestinal and Inflammation. As a strategic co-investor, TVI partners with academic innovators, entrepreneurs and venture investors, offering portfolio companies access to the deep therapeutic-area expertise, translational capabilities and resources of a multinational pharmaceutical company. Across its history the firm has made well over a hundred investments, producing 8 IPOs and 15 acquisitions, with notable exits including HOOKIPA Pharma, Avidity Biosciences and BiomX, and recent portfolio additions such as Accipiter Biosciences, Integra Therapeutics and Degron Therapeutics. The group remained highly active through 2024 and 2025, completing fresh oncology and biotech rounds. Takeda Ventures is led by President and CEO Graeme R. Matin and a team of roughly eleven, with primary investment activity across the United States, Western Europe and Canada. A separate sister unit, Takeda Digital Ventures, founded in 2018, focuses on digital health. By pairing capital with Takeda's translational and therapeutic expertise, TVI backs the preclinical and platform companies most relevant to its parent's pipeline.

Thomson Reuters Ventures (TR Ventures) is an early-stage venture capital fund focused on investing in the next generation of enterprise technology. Backed by the global resources of Thomson Reuters, the firm leverages deep industry expertise and a vast network to help startups grow and succeed. Their portfolio spans companies in areas like artificial intelligence, fintech, legal tech, and data privacy, with notable investments in startups like CentML, Spellbook, and Neo.Tax. TR Ventures takes a highly active approach, working alongside founders to accelerate growth by facilitating strategic partnerships, proof-of-concept integrations, and access to Thomson Reuters' vast resources. They focus on supporting early-stage companies, particularly those in regulated industries like law and finance, where Thomson Reuters' market leadership gives portfolio companies a significant advantage. The fund is particularly known for its ability to connect startups with potential customers and provide valuable insights into complex industries like taxation, legal services, and accounting. Led by Managing Director Tamara Steffens and Principal Investor Joe Dormani, TR Ventures positions itself as a strategic partner to forward-thinking founders aiming to build long-term, impactful companies. Their unique blend of industry insight, global reach, and a hands-on approach makes them a valuable ally for startups looking to scale quickly in competitive markets.

Tamarisc Ventures is a New York-based early-stage venture capital firm founded in 2013 that invests in and helps build companies improving the human habitat through innovation at the intersection of real estate, health and technology. Its thesis spans three connected sectors: real estate innovation and building efficiency (proptech); human betterment through educational and medical technologies; and resource-utilization efficiency, technologies applied to reduce pollution and waste. The firm concentrates on US-based companies at the seed and Series A stages, typically deploying $1M to $20M across the life of an investment and actively leading seed rounds with hands-on strategic guidance. Its small, technical partnership combines venture and operating experience: managing partner David Bates, a former Morningside Ventures investor with an Auckland PhD in chemical and materials engineering; co-founder Ed Walters, a Harvard MBA, former Morningside investor and hospitality-tech executive; co-founder Seng Oon Toh, a Berkeley PhD and former ARM and AMD engineer; and co-founder Justin Yap, a Harvard JD and former IFC/World Bank and corporate lawyer. Across a portfolio of roughly 30 to 41 companies, top sectors are enterprise applications and real estate and construction tech, with holdings including Northspyre, Reggora, Breezeway, Serraview, Critical Asset, Bevi, CleanAir.ai, Getaway, ResortPass, Bode, Marigold Health, Meru Health, Aural Analytics, Huckleberry and Bite. Its most recent tracked investment was in Bite in November 2023. By combining a technically deep team with a habitat-improvement thesis, Tamarisc leads seed rounds in proptech, health and resource-efficiency founders.

Tampa Bay Ventures is a venture capital firm founded in 2021 and based in Tampa, Florida, with a mission to build a vibrant, internationally recognized startup ecosystem in the Tampa Bay region by backing the area's most promising tech-enabled startups. The firm launched its first seed fund targeting $20M and oversubscribed it to roughly $27M by early 2023, with plans to invest in about 25 companies over five years. It invests from seed through Series B, with check sizes commonly cited in the $500K to $2M range, focusing on cybersecurity, e-commerce, healthcare, education technology, finance technology and hardware companies in the Tampa Bay area, and it is willing to lead rounds. The partnership combines founders, angel investors and operators. General Partner Marcus Adolfsson is a serial entrepreneur who founded Smartphone Experts and Mobile Nations, the latter sold to Future Plc for $115M; co-founder Andreas Calabrese began his career at Sweden's Capital A Partners; co-founder Tom Frederick is a multi-exit entrepreneur whose companies were acquired by Xerox and Visual Edge; and co-founder Wesley Barnett is a Lakeland-based investor active in startups and real estate. The team numbers around 14, including seven partners. Across roughly 9 to 15 portfolio companies and 17 tracked investments, holdings include Grifin, a micro-investing app that raised an $11.0M Series A in June 2025; Procoto, a Y Combinator graduate whose round the firm led; Reptrics, a customer-success platform; and Enaia. Its most recent tracked deal was Enaia on October 17, 2024. Tampa Bay Ventures anchors itself in building its regional startup ecosystem.

Tanglin Venture Partners is an early-stage venture capital firm founded in 2018, headquartered in Singapore with an investment office in Bengaluru, India. It seeks to partner with entrepreneurs building fast-growing businesses with large profit pools across India and Southeast Asia, concentrating on consumer-focused technology and business-services companies. Core sectors include SaaS, commerce, fintech and digital health, and the firm primarily writes Series A cheques while also leading earlier and pre-Series B rounds. Tanglin manages roughly $250M in assets across two active funds, holds a deliberately concentrated portfolio of 20 to 32 companies, and deploys cheques of up to $8M; it is reportedly raising a third fund targeting $250M. Its investment philosophy emphasizes focus, patience, authentic long-term founder relationships, and deep thematic plus on-the-ground research. The firm was established by Ravi Venkatesh and is led by Managing Partners Ravi Venkatesh, Sankalp Gupta and Russell Dreisenstock, supported by a team of around 16 including principals such as Nitin Govindan. The portfolio includes two unicorns, Open, which reached unicorn status in 2022, and Moglix, a B2B MRO platform, plus Pocket FM, Plum, Lifelong, Ninjacart, Public, PingSafe (acquired by SentinelOne for over $100M) and Houseware (acquired by LaunchDarkly in February 2025). In 2025 Tanglin made five investments, leading rounds for Beco ($10M pre-Series B), Footprints Childcare ($7.5M) and Matiks ($3.1M pre-Series A); its most recent tracked investment was a follow-on in Plum's $20M Series B in March 2026. Tanglin pairs a concentrated, research-driven approach with a willingness to lead across India and Southeast Asia.

Tao Capital Partners, based in San Francisco, is a versatile venture capital firm known for its broad investment scope and influential portfolio. Notable investments include high-profile companies like Tesla, Uber, SpaceX, and DeepMind, showcasing their commitment to technology, alternative energy, and transportation. They also have significant stakes in sectors such as healthcare, education, sustainable food, and real estate, with investments in companies like Warby Parker, Harry's, and Zymergen. Tao Capital's investment strategy is flexible, engaging with companies across various stages of their lifecycle. They seek out businesses that have a positive impact and support them actively through their growth. Their geographic focus spans primarily North America, particularly the United States, although they do not restrict themselves geographically. The firm’s approach is hands-on, often taking board seats and leveraging their extensive network to add value beyond just capital. They are known for their active involvement in portfolio companies, ensuring they align with Tao’s values and long-term vision. Their team includes experienced professionals with deep industry knowledge, contributing to their strategic investment decisions. For startups looking to connect, Tao Capital prefers those that can demonstrate early traction and have a clear, positive impact. They value innovative solutions that align with their diverse investment interests, ranging from cutting-edge technology to sustainable food and agriculture​.

Tapestry VC is a seed-stage venture capital firm based in San Francisco, California, with additional operations in Europe. Founded in 2021, Tapestry focuses on investing in early-stage technology startups across the US and Europe. The firm targets sectors such as software, fintech, 3D printing, and infrastructure, backing technical and repeat founders who are building next-generation solutions. The firm has almost $100 million in assets under management and has made significant investments in companies like Hopin, Pitch, Zapp, and Nothing. Tapestry VC's team includes industry veterans like Patrick Murphy, who previously started a VC fund for Universal Music Group, and David Kelly, a co-founder of Web Summit. The team emphasizes a hands-on approach, working closely with their portfolio companies to help them scale effectively. Tapestry's investment strategy is rooted in supporting founders who not only bring technical expertise but also have the vision to create market-defining products. The firm prides itself on moving quickly to support its founders, with the aim of turning ambitious ideas into impactful, billion-dollar businesses. For startups looking to partner with Tapestry VC, the firm offers deep industry knowledge, operational support, and a global network that can help accelerate growth and achieve significant milestones.

Target Global is a Berlin-based venture capital firm, managing over €1 billion in assets. It focuses on backing fast-growing startups in fintech, SaaS, mobility, and digital health across Europe, Israel, and the US. Their portfolio includes major players like Delivery Hero, WeFox, and Rapyd. With a focus on seed to growth-stage companies, Target Global typically invests €10-20 million, actively leading rounds and guiding companies through to international success. The firm’s strategy centers on identifying disruptive digital-enabled businesses, often those in underserved markets or emerging sectors like Industry 4.0 and healthtech. Their geographic focus spans Europe, with particular emphasis on Germany, London, and Tel Aviv, but they also make opportunistic investments in emerging economies like Poland and the Baltics. In terms of recent activity, Target Global raised a new €300 million fund to deepen its exposure in fintech and wellness sectors. The firm typically invests 70% of its capital in Europe, 20% in Israel, and the rest in opportunistic global deals. Entrepreneurs seeking funding are encouraged to highlight scalable, tech-driven solutions, as Target looks for businesses that can drive industry-wide change. Led by general partners Yaron Valler and Alex Frolov, the firm combines deep market knowledge with a proactive, hands-on approach, making it a key player in Europe’s venture capital scene.

Tarnagulla Ventures is a life-science-focused venture capital firm founded in 2015 and headquartered in Melbourne, Australia, providing seed and venture capital to promising companies in the healthcare and life-science space. Although Melbourne-based, the firm is global in scope with a particular focus on bringing promising medical technologies to the Australian and US markets, and it backs companies primarily at the seed and Series A stages, willing to lead rounds. Its expertise spans small-molecule, protein and cell-based therapeutics, and it positions itself as a strategic partner that contributes intellectual as well as financial capital. The firm is named after Tarnagulla, an old Australian gold-mining town with family ties to its founders, where the 26.6kg 'Poseidon' gold nugget was found in 1906. Tarnagulla is managed by William and Natalie McNamee: Natalie has been a director since 2015 and leads investment diligence across most portfolio companies, while William, a director since 2016, co-founded and led the development of three life-science companies, Holman Pharmaceuticals, Dalmoral Pharmaceuticals and LimRad. Across roughly eight portfolio companies the firm has notched two NASDAQ IPOs: LB Pharmaceuticals, developer of LB-102 for schizophrenia, listed in September 2025 at a roughly $302M market cap, and Jupiter Neurosciences, whose resveratrol-platform JOTROL targets CNS diseases, exited via IPO in December 2024 at a roughly $132M market cap and whose $2M seed round Tarnagulla led. Other holdings include Azora Therapeutics in autoimmune and inflammatory small molecules and Prevatex in maternal-microbiome probiotics. The firm reported no new investments in 2025.

Tau Ventures, founded in 2019 and based in Palo Alto, California, is a venture capital firm that focuses on early-stage investments in AI-driven technologies. Their investment portfolio spans sectors such as digital health, enterprise software, and automation, including robotics and drones. They typically write initial checks between $500,000 and $1 million, providing seed funding to startups with significant growth potential. The firm was co-founded by Amit Garg and Sanjay Rao, both experienced in venture capital and technology. Amit Garg, with a background from Google and Norwest Venture Partners, focuses primarily on digital health investments. Sanjay Rao, previously with McKinsey and Microsoft, concentrates on enterprise and automation sectors. The team also includes associates like Sharon Huang and Insoo Chang, who bring diverse expertise from biotechnology to strategic investments. Tau Ventures is recognized for its active engagement with portfolio companies, providing strategic guidance and leveraging their extensive network to help startups succeed. Some notable investments include Alaffia Health, a healthcare technology firm, and Tonic, which creates synthetic data for testing and development. With around $85 million in assets under management, Tau Ventures is committed to fostering innovation in AI and supporting startups that aim to make a significant impact in their respective fields​.

Taurus Ventures is an early-stage, technology-focused venture capital firm founded in 2015 and based in New York City, investing in technology-enabled businesses across the United States and Southeast Asia. The firm targets multiple early stages, pre-seed, seed, seed-plus and Series A, and concentrates on sectors including artificial intelligence, healthcare, climate, consumer and commerce, seeking founders with strong teams, scalable business models and the ability to disrupt traditional industries through innovative technology, typically as a co-investor. Taurus is led by co-founders Hemant Bhardwaj, Managing Partner, and Win Thanapisitikul, with partner Gaurav Batra; Bhardwaj brings extensive venture-capital and technology-investment experience identifying and supporting early-stage startups. Over roughly six years the firm has built a portfolio of around 64 companies that includes three unicorns, Solugen, a sustainable-chemicals company that secured a $214M DOE loan, People.ai and Fair, alongside one IPO and two acquisitions. Other notable holdings span its US and Southeast Asia footprints: Tigerhall, Neuron, Infradigital, Momos, Multifactor in AI-agent account security, Cactus AI, Starcloud building data centers in space, Jiko, IUNU in greenhouse monitoring, KarmaCheck and ProducePay. Recent activity includes a Series A investment in Momos in September 2024 and a most-recent tracked investment in Barndoor AI on May 20, 2025, with first-time backing of Multifactor and a follow-on in Tigerhall during 2025. By bridging the US and Southeast Asian ecosystems, Taurus Ventures backs early-stage technology founders across AI, healthcare, climate and commerce.

TCP Venture Capital is a Baltimore, Maryland-based early-stage, technology-focused venture capital firm founded in 2012 that partners with entrepreneurs to build great businesses. The firm invests in early-stage companies across technology, education, healthcare, cybersecurity, analytics and advanced-materials sectors, concentrating on unique technology applications and explicitly excluding franchises, brick-and-mortar operations and online retail. Its flagship Propel Baltimore Fund makes investments in early-stage technology companies based in, or willing to relocate to, Baltimore, with an explicit mission to address the city's shortage of early-stage capital, encourage entrepreneurial activity and create high-paying jobs. TCP was founded by Christopher College and Stuart Sutley and is managed by a team with over 140 years of combined experience, and it is willing to lead rounds. Managing Partner Christopher College is a seasoned venture investor who has closed more than 100 deals totaling over $2.5 billion and previously headed the Private Finance Group at Stifel Nicolaus; Partner Stuart Sutley is a University of Virginia graduate, former US Marine Corps infantry officer and healthcare-company founder. Across roughly 30 to 35 investments the portfolio has produced eight acquisitions, including ZeroFox, RedOwl, Protenus and Rocket Doctor (acquired by Canada's Treatment AI), with other holdings such as WellDoc, EcoMap, Indicio, Link Labs, Traitify, Yet Analytics, Pixelligent Technologies, emocha and Minnowtech. Its most recent tracked investment was a Series A in Baltimore-based Infinity Bio in June 2025. By anchoring its flagship fund in Baltimore, TCP backs regional technology founders while addressing a local capital gap.

TDF Ventures, founded in 2004, is an early-stage venture capital firm with offices in Washington DC and Silicon Valley. The firm focuses on startups that serve enterprise markets within infrastructure, software, and services sectors (IaaS, SaaS, XaaS). They manage a permanent pool of capital and are currently investing out of Fund IV, which has a $150 million allocation. TDF Ventures has a diverse portfolio with notable investments in companies like Omnispace, which recently expanded its spectrum portfolio, and Rewst, which raised $31 million in a Series B round to extend its leadership in the MSP automation market. Other active investments include Allstacks, Osano, and BlackCloak, which won the 2023 SC Media Award for Best Emerging Technology of the Year. The firm's investment strategy includes both financial backing and strategic support, helping portfolio companies with network building, brand exposure, talent acquisition, and subsequent funding rounds. The team at TDF Ventures includes partners and principals with extensive experience in the venture capital and technology sectors, such as Jim Pastoriza and Steven Mankoff.

TDJ Pitango Ventures is a Polish-Israeli, technology-focused venture capital fund founded in 2017 and based in Warsaw, Poland. It is a joint venture between TDJ, a Polish family-owned industrial group active in equity, venture, real estate, finance and philanthropy whose portfolio includes Warsaw-listed companies FAMUR, Zamet and PGO, and Pitango, Israel's largest venture capital fund, with around $2 billion under management, operating since 1993 with more than 200 investments and over 80 exits. The fund was also created with support from Poland's National Center for Research and Development. Investing on a 'smart money' formula, TDJ Pitango concentrates on early and growth phases, deploying $1M to $5M per round into startups with strong technology operating in large or fast-growing markets, and targets sectors including big data and analytics, artificial intelligence, machine learning, medical devices and digital health, software, mobile technology, media and IoT. It is founder-friendly, takes minority stakes and prefers to co-invest with other value-add investors, supporting portfolio companies with network access, senior talent, fundraising help and exit support. The fund is led by Managing Partners Wojciech Fedorowicz and Daniel Star. Across roughly 10 portfolio companies, including Tylko (custom furniture, into which it invested nearly 15M PLN), Cosmose AI (approaching Polish-unicorn status at a roughly $500M valuation), Neptune, StethoMe, CallPage, GG Predict, Syntoil, Vocaly and SmartDust, it has made about five seed investments and two Series A investments. Its most recent tracked investment was in Visby Medical in June 2025. The fund bridges Polish industrial heritage and Israeli venture expertise.

TEAMFund (Transforming Equity and Access in MedTech) is a global-health impact investor and advisor founded in 2016, with a US base in San Francisco, California. It runs a distinctive hybrid structure that couples a for-profit impact investment fund with a non-profit programming arm; the non-profit informs investments through rigorous research and provides portfolio companies with wraparound support, drawing on an 80-plus worldwide team of executive-level advisors and CEOs from leading healthcare multinationals. Its mission is to expand access to affordable, appropriate and sustainable medical technologies, digital health and facilitating technologies that address unmet health needs in resource-constrained, underserved populations, with a thesis that non-communicable diseases pose the greatest threat in low- and middle-income countries. The firm invests in commercial-stage companies and focuses geographically on India and Sub-Saharan Africa, where local entrepreneurs are often best positioned to close care gaps, typically as a co-investor. TEAMFund closed its inaugural $30M impact fund in 2019, structured with a 10-year horizon and a plan for 8 to 10 portfolio companies, and has since raised a follow-on Impact Fund II. It is co-founded and co-chaired by Tim Ring, former Chairman and CEO of C.R. Bard, and Kathryn Gleason, former senior partner at Morgan Lewis, and led day-to-day by Managing Partner Yousuf Mazhar. Portfolio companies include Qure.ai, MediBuddy, Tricog Health, Forus Health, JanaCare, EchoNous and Vezeeta, which collectively delivered tens of millions of patient services. Its most recent tracked activity was participation in Qure.ai's $65M Series D in September 2024. TEAMFund pairs impact capital with deep medtech advisory support.

Teamworthy Ventures is a venture capital firm that invests in early to growth-stage companies, focusing on building long-term relationships with talented entrepreneurial teams. Their portfolio includes leading software and software-enabled services companies such as Toast, SeatGeek, Weave, Carta, Capsule, CampusLogic, G2, Ibotta, OpenGov, Foursquare, Vestwell, Affinity, and Slice. The firm's mission is to partner with outstanding entrepreneurial teams to build companies of purpose, integrity, and enduring value. They emphasize values such as teamwork, service, integrity, creativity, enthusiasm, initiative, craftsmanship, learning, prudence, fortitude, humility, and thrift. Teamworthy strives to be a worthy partner by providing not just capital but also strategic support and mentorship to help entrepreneurs achieve their full potential. Their investment team includes experienced professionals like Senior Associate Kyle Limpic, Associate Emma Barrett, and Associate Josiah Meadows, who bring diverse backgrounds and expertise to the firm. Teamworthy Ventures operates out of Greenwich, Connecticut, and Nashville, Tennessee, providing a robust support network for their portfolio companies.

Tech Coast Angels (TCA) is one of the largest and most active angel investor networks in the U.S., particularly focused on Southern California. Since its founding in 1997, TCA has funded over 540 companies, providing more than $300 million in early-stage capital. Its portfolio includes notable successes such as Apeel (now a unicorn) and Procore. TCA’s investments span a variety of industries, including healthcare, high-tech, and consumer products. TCA primarily invests in seed and early Series A rounds, often in California-based startups but also extending its reach across the U.S. and occasionally internationally. The group is known for not only providing capital but also hands-on mentorship and operational support. With around 400 members across several regional networks, TCA brings deep expertise and valuable connections to the table. Recently, TCA has increased its focus on syndicating deals with other angel groups and VCs, helping startups secure additional capital. Entrepreneurs looking to partner with TCA should demonstrate strong market potential and scalability, while leveraging the network’s robust mentorship and support system to build a sustainable business​.

Tech Council Ventures is an early-stage venture capital firm based in Summit, New Jersey that invests Seed and Series A financing into the Mid-Atlantic region's most promising growth technology companies. Originally founded in 2001 as the NJTC Venture Fund, it rebranded to Tech Council Ventures in 2016 and operates as the venture arm of TechUnited:NJ, formerly the NJ Technology Council, one of the largest and most active technology councils in the United States with more than 500,000 innovator members. That affiliation is the firm's core differentiator: portfolio companies gain access to an unmatched network of customers, key team recruits, business partners and service providers. With roughly $175M in assets under management across eight funds and five decades of collective team experience, the firm writes checks of $500K to $3M into startups spanning technology, enterprise software, biotech, life sciences, healthcare, media, telecom, cleantech and edtech, and it is willing to lead rounds. Its investment team is led by Managing Partner and Founder Jim Gunton, a 20-plus-year investor formerly with Edison Venture Fund and Oracle, alongside Managing Partner Steve Socolof and Partner Mark Kolb, a healthcare entrepreneur and former CEO of Bergen Medical Products. Tech Council Ventures has made roughly 59 investments with four exits, including notable holdings such as Achieve3000, Amber Road, CytoSorbents, InstaMed and IntegriChain. The firm is currently deploying its third fund; its most recent investment was participation in PolyGone Systems' $4M Seed round in February 2026. By tying its capital to one of the country's largest technology-council networks, the firm backs Mid-Atlantic founders.

Tech Square Ventures (TSV) is an Atlanta-based early-stage venture capital firm founded in 2014. The firm focuses on investing in B2B enterprise software, marketplace, and platform technology companies. TSV’s investment strategy revolves around providing capital, connections, and collaboration to visionary entrepreneurs, helping them scale their businesses in high-growth sectors like logistics, applied AI, sustainability, and infrastructure. TSV primarily targets early-stage investments, typically at the Seed stage, with initial check sizes ranging from $500K to $3 million. They also participate selectively in pre-seed and Series A rounds. The firm has a strong geographic focus on the Southeastern U.S., where they invest in high-potential startups from what they call the "Super South," the nation's fastest-growing innovation region. The firm’s portfolio includes notable startups such as The Mom Project, Slip Robotics, and Saleo, showcasing its commitment to backing companies that redefine enterprise operations. Through Engage, its corporate innovation platform, TSV connects startups with Fortune 500 corporations, facilitating growth through access to customers and markets. Founded by Blake Patton, Tech Square Ventures is deeply embedded in Atlanta’s tech ecosystem, leveraging its proximity to Georgia Tech’s Technology Square and a vast network of entrepreneurs, corporate partners, and academic institutions to fuel innovation.

TechAccel (Technology Acceleration Partners) is a Kansas City-area technology and venture development organization founded in 2014 by Michael Helmstetter together with Kansas State University and the Bicknell Family Holding Company. It describes itself as a first-of-its-kind hybrid that pairs equity capital with R&D: its 'Equity+ Science Advancement' model invests in startups and simultaneously funds research at universities and partners to bridge the gap between scientific discovery and commercialization. The firm focuses on agriculture (agtech), animal health and nutrition, and food technology, sectors its leadership argues are under-appreciated by mainstream venture capital that concentrates on human health. Rather than operating as a conventional pooled fund, TechAccel is an operating company backed by Kansas City-based high-net-worth individuals and family offices, calling capital as needed to fund specific projects; individual investments typically range from about $500,000 to $1 million, and it generally invests as a co-investor. It is led by Co-Founder, President and CEO Dr. Michael Helmstetter, who brings more than 30 years of startup, spin-off and technology-advancement experience across agriculture, defense and biotechnology. TechAccel's portfolio of roughly a dozen disclosed companies has produced one IPO, GreenLight Biosciences, and one acquisition, Agrivida, and includes investments such as Benson Hill Biosystems, where it joined a $25M Series B in crop science, and Epicrop Technologies, a crop-epigenetics company. It also co-formed Covenant Animal Health Partners, later sold to NovaQuest Capital Management in 2021. By coupling equity investment with funded science advancement, TechAccel backs agriculture, animal-health and food-technology innovation from discovery through commercialization.